A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Jonsson Comprehensive Cancer Center
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Imperial College London
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
ImmunoFrontier, Inc.
Astellas Pharma Inc